Clinical trial
Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients…
NCT00006136 · Boston University, Other · Completed
Key facts
| NCT number | NCT00006136 |
|---|---|
| Title | Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia |
| Lead sponsor | Boston University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Beta-Thalassemia |
| Intervention type | Drug |
| Interventions | arginine butyrate, epoetin alfa |
| Enrollment | 15 |
| Start date | Mar 1, 1999 |
| First posted | Aug 4, 2000 |
| Last update posted | Nov 8, 2005 |
| Countries | United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: